Neonatal respiratory distress syndrome: Chest X-ray or lung ultrasound? A systematic review

Background and aim: Neonatal respiratory distress syndrome (NRDS) is a leading cause of morbidity in preterm new-born babies (< 37 weeks gestation age [GA]). The current diagnostic reference standard includes clinical testing and chest radiography (CXR) with associated exposure to ionising radiation. The aim of this review was to compare the diagnostic accuracy of lung ultrasound (LUS) against the reference standard in symptomatic neonates of ≤ 42 weeks GA. Methods: A systematic search of literature published between 1990 and 2016 identified 803 potentially relevant studies. Six studies met the review inclusion criteria and were retrieved for analysis. Quality assessment was performed before data extraction and meta-analysis. Results: Four prospective cohort studies and two case control studies included 480 neonates. All studies were of moderate methodological quality although heterogeneity was evident across the studies. The pooled sensitivity and specificity of LUS were 97% (95% confidence interval [CI] 94%-99%) and 91% (CI: 86%-95%) respectively. False positive diagnoses were made in sixteen cases due to pneumonia (n=8), transient tachypnoea (n=3), pneumothorax (n=1) and meconium aspiration syndrome (n=1); the diagnoses of the remaining three false positive results were not specified. False negatives diagnoses occurred in nine cases, only two were specified as air-leak syndromes. Conclusions: LUS was highly sensitive for the detection of NRDS although there is potential to miss co-morbid air-leak syndromes (ALS). Further research into LUS diagnostic accuracy for neonatal ALS and economic modelling for service integration is required before LUS can replace CXR as the imaging component of the reference standard

Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial

Importance: The long-term effects of surfactant administration via a thin catheter (minimally invasive surfactant therapy [MIST]) in preterm infants with respiratory distress syndrome remain to be definitively clarified. / Objective: To examine the effect of MIST on death or neurodevelopmental disability (NDD) at 2 years' corrected age. / Design, Setting, and Participants: Follow-up study of a randomized clinical trial with blinding of clinicians and outcome assessors conducted in 33 tertiary-level neonatal intensive care units in 11 countries. The trial included 486 infants with a gestational age of 25 to 28 weeks supported with continuous positive airway pressure (CPAP). Collection of follow-up data at 2 years' corrected age was completed on December 9, 2022. / Interventions: Infants assigned to MIST (n = 242) received exogenous surfactant (200 mg/kg poractant alfa) via a thin catheter; those assigned to the control group (n = 244) received sham treatment. / Main Outcomes and Measures: The key secondary outcome of death or moderate to severe NDD was assessed at 2 years' corrected age. Other secondary outcomes included components of this composite outcome, as well as hospitalizations for respiratory illness and parent-reported wheezing or breathing difficulty in the first 2 years. / Results: Among the 486 infants randomized, 453 had follow-up data available (median gestation, 27.3 weeks; 228 females [50.3%]); data on the key secondary outcome were available in 434 infants. Death or NDD occurred in 78 infants (36.3%) in the MIST group and 79 (36.1%) in the control group (risk difference, 0% [95% CI, -7.6% to 7.7%]; relative risk [RR], 1.0 [95% CI, 0.81-1.24]); components of this outcome did not differ significantly between groups. Secondary respiratory outcomes favored the MIST group. Hospitalization with respiratory illness occurred in 49 infants (25.1%) in the MIST group vs 78 (38.2%) in the control group (RR, 0.66 [95% CI, 0.54-0.81]) and parent-reported wheezing or breathing difficulty in 73 (40.6%) vs 104 (53.6%), respectively (RR, 0.76 [95% CI, 0.63-0.90]). / Conclusions and Relevance: In this follow-up study of a randomized clinical trial of preterm infants with respiratory distress syndrome supported with CPAP, MIST compared with sham treatment did not reduce the incidence of death or NDD by 2 years of age. However, infants who received MIST had lower rates of adverse respiratory outcomes during their first 2 years of life. / Trial Registration: anzctr.org.au Identifier: ACTRN12611000916943

A comparison of intraosseous and intravenous adrenaline administration during resuscitation of asphyxiated newborn lambs

Objective: Intraosseous access is recommended as a reasonable alternative for vascular access during newborn resuscitation if umbilical access is unavailable, but there are minimal reported data in newborns. We compared intraosseous with intravenous adrenaline administration, during resuscitation of severely asphyxiated lambs at birth. Methods: Near-term lambs (139 days’ gestation) were instrumented antenatally for measurement of carotid and pulmonary blood flow, and systemic blood pressure. Intrapartum asphyxia was induced by umbilical cord clamping, until asystole. Resuscitation commenced with positive pressure ventilation followed by chest compressions and lambs received either intraosseous or central intravenous adrenaline (10 micrograms/kg); adrenaline administration was repeated every 3 minutes until return of spontaneous circulation (ROSC). Lambs were maintained for 30 minutes after ROSC. Plasma adrenaline levels were measured before cord clamping, at end asphyxia, and at 3 and 15 minutes post-ROSC. Results: ROSC was successful in 7/9 intraosseous adrenaline lambs and 10/12 intravenous adrenaline lambs. The time and number of adrenaline doses required to achieve ROSC were similar between groups, as were the achieved plasma adrenaline levels. Lambs in both groups displayed a similar marked overshoot in systemic blood pressure and carotid blood flow after ROSC. Blood gas parameters improved more quickly in the intraosseous lambs in the first 3 minutes, but were otherwise similar over the 30 minutes after ROSC. Conclusions: Intraosseous adrenaline administration results in similar outcomes to intravenous adrenaline during resuscitation of asphyxiated newborn lambs. These findings support the inclusion of intraosseous access as a route for adrenaline administration in current guidelines.</p

Devices for administering ventilation at birth: a systematic review

CONTEXT: Positive pressure ventilation (PPV) is the most important intervention during neonatal resuscitation. OBJECTIVE: To compare T-piece resuscitators (TPRs), self-inflating bags (SIBs), and flow-inflating bags for newborns receiving PPV during delivery room resuscitation. DATA SOURCES: Medline, Embase, Cumulative Index to Nursing and Allied Health Literature, Cochrane Database of Systematic Reviews, and trial registries (inception to December 2020). STUDY SELECTION: Randomized, quasi-randomized, interrupted time series, controlled before-and-after, and cohort studies were included without language restrictions. DATA EXTRACTION: Two researchers independently extracted data, assessed the risk of bias, and evaluated the certainty of evidence. The primary outcome was in-hospital mortality. When appropriate, data were pooled by using fixed-effect models. RESULTS: Meta-analysis of 4 randomized controlled trials (1247 patients) revealed no significant difference between TPR and SIB for in-hospital mortality (risk ratio 0.74; 95% confidence interval [CI] 0.40 to 1.34). Resuscitation with a TPR resulted in a shorter duration of PPV (mean difference −19.8 seconds; 95% CI −27.7 to −12.0 seconds) and lower risk of bronchopulmonary dysplasia (risk ratio 0.64; 95% CI 0.43 to 0.95; number needed to treat 32). No differences in clinically relevant outcomes were found in 2 randomized controlled trials used to compare SIBs with and without positive end-expiratory pressure valves. No studies used to evaluate flow-inflating bags were found. LIMITATIONS: Certainty of evidence was very low or low for most outcomes. CONCLUSIONS: Resuscitation with a TPR compared with an SIB reduces the duration of PPV and risk of bronchopulmonary dysplasia. A strong recommendation cannot be made because of the low certainty of evidence. There is insufficient evidence to determine the effectiveness of positive end-expiratory pressure valves when used with SIBs.</p